SCYNEXIS to Present at the 17th Annual Needham Healthcare Conference

Wednesday, March 21, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

JERSEY CITY, N.J., March 21, 2018 /PRNewswire/ -- SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company delivering innovative

anti-infective therapies for difficult-to-treat and often life-threatening infections, today announced that the Company will present at the 17th Annual Needham Healthcare Conference at the Westin New York Grand Central on Wednesday,
March 28, 2018
at 3:00 p.m. ET.

A live webcast will be available on the Investors section of the Company's website: www.scynexis.com. A replay of the presentation will be available approximately two hours after the event and will be available for two weeks following the presentation.

About SCYNEXISSCYNEXIS, Inc. (NASDAQ: SCYX) is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. The SCYNEXIS team has extensive experience in the life sciences industry, discovering and developing more than 30 innovative medicines over a broad range of therapeutic areas. The Company's lead product candidate, SCY-078, is a novel IV/oral antifungal agent in Phase 2 clinical and preclinical development for the treatment of several serious and life-threatening invasive fungal infections caused by Candida and Aspergillus species. For more information, visit www.scynexis.com.

CONTACT:

Investor RelationsSusan KimArgot PartnersTel: 212-203-4433susan@argotpartners.com

Media RelationsGeorge E. MacDougallMacDougall Biomedical CommunicationsTel: 781-235-3093george@macbiocom.com 

 

Cision View original content:http://www.prnewswire.com/news-releases/scynexis-to-present-at-the-17th-annual-needham-healthcare-conference-300617321.html

SOURCE SCYNEXIS, Inc.

Advertisement


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store